Incyte Corporation
INCYNASDAQHealthcare● Active
$99.40
$-2.99(-2.92%)
Market Cap$19.9B
P/E Ratio—
52W High$112.29
52W Low$66.74
Incyte Corporation (INCY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
INCY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 28, 2026EPS Actual
$1.81
Est. $1.38 · +31.2%
Revenue
$1.27B
Est. $1.22B · +4.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 28, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
INCY reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $1.80 | — | — | — | $1.37B | — |
| ▲ Q2 FY2026 | Apr 28, 2026 | $1.38 | $1.81 | +31.2% | $1.27B | $1.22B | +4.7% |
| ▼ Q1 FY2026 | Feb 10, 2026 | $1.90 | $1.80 | -5.3% | $1.51B | $1.35B | +11.2% |
| ▲ Q4 FY2025 | Oct 28, 2025 | $1.66 | $2.26 | +36.1% | $1.37B | $1.35B | +0.9% |
| ▲ Q3 FY2025 | Jul 29, 2025 | $1.39 | $1.57 | +12.9% | $1.22B | $1.26B | -3.3% |
| ▲ Q2 FY2025 | Apr 29, 2025 | $1.01 | $1.16 | +14.8% | $1.05B | $1.15B | -8.7% |
| ▼ Q1 FY2025 | Feb 10, 2025 | $1.57 | $1.43 | -8.9% | $1.18B | $1.00B | +17.3% |
| ▼ Q4 FY2024 | Oct 29, 2024 | $1.12 | $1.07 | -4.5% | $1.14B | $1.14B | -0.5% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$1.80
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 28, 2026Beat
EPS Actual
$1.81
EPS Est.
$1.38
EPS Surpr.
+31.2%
Revenue
$1.27B
Q1 FY2026
Feb 10, 2026Miss
EPS Actual
$1.80
EPS Est.
$1.90
EPS Surpr.
-5.3%
Revenue
$1.51B
Q4 FY2025
Oct 28, 2025Beat
EPS Actual
$2.26
EPS Est.
$1.66
EPS Surpr.
+36.1%
Revenue
$1.37B
Q3 FY2025
Jul 29, 2025Beat
EPS Actual
$1.57
EPS Est.
$1.39
EPS Surpr.
+12.9%
Revenue
$1.22B
Q2 FY2025
Apr 29, 2025Beat
EPS Actual
$1.16
EPS Est.
$1.01
EPS Surpr.
+14.8%
Revenue
$1.05B
Q1 FY2025
Feb 10, 2025Miss
EPS Actual
$1.43
EPS Est.
$1.57
EPS Surpr.
-8.9%
Revenue
$1.18B
Q4 FY2024
Oct 29, 2024Miss
EPS Actual
$1.07
EPS Est.
$1.12
EPS Surpr.
-4.5%
Revenue
$1.14B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.99 | $2.07 | $2.19 | 9 |
| Q3 FY2028 | $2.15 | $2.23 | $2.37 | 7 |
| Q2 FY2028 | $2.44 | $2.53 | $2.68 | 6 |
| Q1 FY2028 | $2.07 | $2.15 | $2.28 | 6 |
| Q4 FY2027 | $2.78 | $2.89 | $3.06 | 5 |
| Q3 FY2027 | $2.35 | $2.44 | $2.59 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.5B | $1.6B | $1.6B | 6 |
| Q3 FY2028 | $1.5B | $1.5B | $1.6B | 11 |
| Q2 FY2028 | $1.6B | $1.6B | $1.7B | 6 |
| Q1 FY2028 | $1.4B | $1.4B | $1.5B | 6 |
| Q4 FY2027 | $1.6B | $1.7B | $1.8B | 7 |
| Q3 FY2027 | $1.5B | $1.6B | $1.6B | 8 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 28, 2026 | +31.2% | $95.72 | $97.74 | +2.11% |
| ▼ Q1 FY2026 | Feb 10, 2026 | -5.3% | $109.03 | $100.05 | -8.24% |
| ▲ Q4 FY2025 | Oct 28, 2025 | +36.1% | $93.08 | $91.65 | -1.54% |
| ▲ Q3 FY2025 | Jul 29, 2025 | +12.9% | $70.16 | $77.38 | +10.29% |
| ▲ Q2 FY2025 | Apr 29, 2025 | +14.8% | $59.52 | $60.43 | +1.53% |
| ▼ Q1 FY2025 | Feb 10, 2025 | -8.9% | $74.13 | $68.30 | -7.86% |
| ▼ Q4 FY2024 | Oct 29, 2024 | -4.5% | $65.69 | $73.60 | +12.04% |
| ▼ Q3 FY2024 | Jul 30, 2024 | -333.3% | $68.59 | $67.79 | -1.17% |
Q2 FY2026+2.11%
Report Date
Apr 28, 2026
EPS Beat/Miss
+31.2%
Price Before
$95.72
Price After
$97.74
Q1 FY2026-8.24%
Report Date
Feb 10, 2026
EPS Beat/Miss
-5.3%
Price Before
$109.03
Price After
$100.05
Q4 FY2025-1.54%
Report Date
Oct 28, 2025
EPS Beat/Miss
+36.1%
Price Before
$93.08
Price After
$91.65
Q3 FY2025+10.29%
Report Date
Jul 29, 2025
EPS Beat/Miss
+12.9%
Price Before
$70.16
Price After
$77.38
Q2 FY2025+1.53%
Report Date
Apr 29, 2025
EPS Beat/Miss
+14.8%
Price Before
$59.52
Price After
$60.43
Q1 FY2025-7.86%
Report Date
Feb 10, 2025
EPS Beat/Miss
-8.9%
Price Before
$74.13
Price After
$68.30
Q4 FY2024+12.04%
Report Date
Oct 29, 2024
EPS Beat/Miss
-4.5%
Price Before
$65.69
Price After
$73.60
Q3 FY2024-1.17%
Report Date
Jul 30, 2024
EPS Beat/Miss
-333.3%
Price Before
$68.59
Price After
$67.79
Avg Beat Reaction+3.10%
Avg Miss Reaction-1.31%
Beat Rate4 / 8 quarters
Largest Move+12.04% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: INCY ends December
Incyte Corporation (INCY) most recently reported earnings on April 28, 2026 for Q2 FY2026, posting EPS of $1.81 — beating the analyst consensus of $1.38 by +31.2%. The next INCY earnings date is expected around September 1, 2026.
Each quarter, investors track INCY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. INCY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
INCY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
INCY earnings · 5 questionsIncyte Corporation's next earnings report is expected around September 1, 2026. INCY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; INCY historically reports after market close (AMC).
INCY earnings datewhen is INCY earningsINCY next earnings datewhen does INCY report earningsINCY earnings calendar
▸ Source: FMP · Incyte Corporation SEC filings · US GAAP · Incyte Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026